Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-09 4:03 pm Sale |
2024-06-03 | 13G | iSpecimen Inc. ISPC |
James G. Wolf | 25,250 3.800% |
-14,287 (-36.13%) |
Filing History |
| 2023-01-23 1:23 pm Purchase |
2022-11-23 | 13D | Enzo Biochem, Inc. ENZ |
James G. Wolf | 4,942,400 10.140% |
773,900 (+18.57%) |
Filing History |
| 2022-12-27 1:31 pm Purchase |
2022-12-23 | 13G | iSpecimen Inc. ISPC |
James G. Wolf | 39,537 9.030% |
12,324 (+45.29%) |
Filing History |
| 2022-11-23 11:33 am Purchase |
2022-11-23 | 13D | Enzo Biochem, Inc. ENZ |
James G. Wolf | 4,168,500 8.560% |
54,000 (+1.31%) |
Filing History |
| 2022-10-26 1:07 pm Purchase |
2022-10-18 | 13D | Enzo Biochem, Inc. ENZ |
James G. Wolf | 4,114,500 8.450% |
852,000 (+26.11%) |
Filing History |
| 2022-09-27 9:34 pm Purchase |
2022-09-23 | 13G | iSpecimen Inc. ISPC |
James G. Wolf | 27,213 6.130% |
27,213 (New Position) |
Filing History |
| 2021-11-15 12:50 pm Purchase |
2021-10-15 | 13D | Enzo Biochem, Inc. ENZ |
James G. Wolf | 3,262,500 6.730% |
621,800 (+23.55%) |
Filing History |
| 2021-10-01 12:38 pm Purchase |
2021-09-30 | 13D | Enzo Biochem, Inc. ENZ |
James G. Wolf | 2,640,700 5.400% |
79,400 (+3.10%) |
Filing History |
| 2021-08-20 2:39 pm Purchase |
2021-08-10 | 13G | Enzo Biochem, Inc. ENZ |
James G. Wolf | 2,561,300 5.300% |
2,561,300 (New Position) |
Filing History |